Evidence map›Paper›PMID 42878263›Full record

ArticleChemistry & biodiversity2026

Isolated Cembranoid Diterpenes From Sarcophyton tenuispiculatum and Semi‑Synthetic Derivatives with Pro‑Apoptotic Activity in Breast Cancer Cells.

Samin Mousavi, Afsaneh Yegdaneh, Mahmoud Aghaei, Mustafa Ghanadian

Abstract read
In one paragraph

Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Samin MousaviDepartment of Pharmacognosy, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID https://orcid.org/0009-0001-0830-4901
Afsaneh YegdanehDepartment of Pharmacognosy, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
Mahmoud AghaeiDepartment of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
Mustafa GhanadianIsfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID https://orcid.org/0000-0001-6446-4734

Funding

Isfahan University of Medical Sciences 3401376
6 · The paper itself

Abstract

The soft coral Sarcophyton tenuispiculatum was investigated for its secondary metabolites, leading to the isolation of four natural isolates, including 7α,8α-epoxy-1(15),3,11-cembratriene-16,2β-olide (1), 2β,16,7α,8α-diEpoxy-1(15),3,11-cembratriene (2), apo-9'-fucoxanthinone (3), and (+)-viridiflorol (4). Semi-synthetic modification of compound 1 produced five new cembranoids: epi-Trochelioid B (5), chlorobenzocembrin (6), benzocembrin (7), nitrobenzocembrin (8), and Trochelioid C (9). Structural elucidation was achieved using extensive spectroscopic analyses, including 1D/2D NMR and HR-ESI-MS. Biological evaluation demonstrated that chlorobenzocembrin (6) exhibited more cytotoxic activity against breast cancer cell lines MCF-7 and MDA-MB-231, inducing apoptosis through ROS accumulation and caspase-6 activation. Acute toxicity studies in mice revealed hepatotoxicity and nephrotoxicity in doses > 250 mg/kg. Preliminary antiproliferative SAR highlights that epoxide ring opening followed by aryl substitution at C‑7 on 7α,8α-epoxy-1(15),3,11-cembratriene-16,2β-olide enhanced cytotoxic activity and suggests that incorporating substituents associated with enhanced cytotoxic activity at the same position may represent a promising strategy for semi‑synthetic optimization of cembranoid scaffolds toward more potent and selective anticancer agents.

Indexed as

AnthozoaAntineoplastic AgentsApoptosisBreast NeoplasmsDiterpenesAnimalsCell Line, TumorCell ProliferationDrug Screening Assays, AntitumorFemaleHumansMolecular ConformationMolecular StructureReactive Oxygen SpeciesStructure-Activity RelationshipAntineoplastic AgentsDiterpenesReactive Oxygen Speciesacute toxicityapoptosisbreast cancerCaspase 6cembranoidsreactive oxygen speciesSarcophytonsemi‐synthesis

Identifiers

PMID42878263
PMCPMC13670404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.